-transparent.png){kind=logo}
The authors reported the effect of high dose intravenous immunoglobulin therapy in 18 patients with chronic autoimmune thrombocytopenic purpura. A good but transitory response was observed in 60% of the cases. The intensity of the response was variable, the duration was between 11 and 26 days. The mechanism of the effect of this therapy is poorly understood. Since this therapy is expensive and the response inconsistent and transitory, the indications are limited.
Related Publications
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
January 1999,
La Revue de medecine interne,
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
November 1983,
Presse medicale (Paris, France : 1983),
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
November 1983,
Presse medicale (Paris, France : 1983),
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
November 1983,
Presse medicale (Paris, France : 1983),
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
December 1999,
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
January 1987,
Annales francaises d'anesthesie et de reanimation,
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
January 1996,
La Revue de medecine interne,
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
February 1990,
Medicina clinica,
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
October 1985,
Revista clinica espanola,
M Janvier, and
J P Clauvel, and
G Tobelem, and
W Vainchenker, and
M Seligmann, and
M Boiron
January 1993,
Annales de medecine interne,
